In non-muscle invasive
bladder cancer (NMIBC)

Is

there

space

to do more after BCG?

When BCG fails, radical cystectomy is the
primary AUA/SUO-recommended treatment
option for patients who are eligible with high-risk NMIBC.
While therapies after BCG failure are available for those
who are ineligible or unwilling to undergo surgery, additional
options could help these patients.1

test

In non-muscle invasive
bladder cancer (NMIBC)

Is

there

space

to do more after BCG?

When BCG fails, radical cystectomy is the only AUA-recommended treatment option for patients with high-risk NMIBC. Additional therapies after BCG failure could help patients, especially those who are ineligible or unwilling to undergo surgery.1

In non-muscle invasive
bladder cancer (NMIBC)

Is

there

space

to do more after BCG?

When BCG fails, radical cystectomy is the only AUA-recommended treatment option for patients with high-risk NMIBC. Additional therapies after BCG failure could help patients, especially those who are ineligible or unwilling to undergo surgery.1

References: 1. American Urological Association. (2020). Diagnosis and Treatment of Non Muscle Invasive Bladder Cancer: AUA/SUO Joint Guideline (2020). https://www.auanet.org//guidelines/bladder-cancer-non-muscle-invasive-guideline.

Copyright FerGene, Inc. 2020/11 US-URONC-2000010